Escin Iia

CAS : 158732-55-9

Ref. 3D-IGA73255

Informations sur le produit

• Nom: Escin Iia
• Synonymes: (3β,16α,21β,22α)-22-Acetoxy-16,24,28-trihydroxy-21-{[(2E)-2-methylbut-2-enoyl]oxy}olean-12-en-3-yl β-D-glucopyranosyl-(1->4)-[β-D-xylopyranosyl-(1->, 2)]-β-D-glucopyranosiduronic acid, 2-butenoic acid, 2-methyl-, (3β,16α,21β,22α)-22-(acetyloxy)-3-[[O-β-D-glucopyranosyl-(1-> 4)-O-[β-D-xylopyranosyl-(1->2)]-β-D-glucopyranuronosyl]oxy]-16,24,28-trihydroxyolean-12-en-21-yl ester, (2E)-, (3beta,16alpha,21beta,22alpha)-22-(acetyloxy)-16,24,28-trihydroxy-21-{[(2E)-2-methylbut-2-enoyl]oxy}olean-12-en-3-yl beta-D-glucopyranosyl-(1->4)-[beta-D-xylopyranosyl-(1->2)]-beta-D-glucopyranosiduronic acid

Description

Escin Iia is a peptide made from the extract of horse chestnut seed. It is a potent inhibitor of phosphodiesterase-4, which is responsible for degradation of cAMP in cells. Escin Iia has been shown to activate ion channels and inhibit acetylcholine esterase, which are involved in regulating neurotransmitter release at synapses. It also inhibits the binding of an antibody to its receptor, which may have applications in research and development of pharmaceuticals. Escin Iia has been used as a research tool for studying protein interactions, cell biology, pharmacology, and life science.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 1,101.2 g/mol
• Formule: C₅₄H₈₄O₂₃
• Degré de pureté: Min. 95%